Table 1 Patients’ profiles
Haemodialysis (n = 55) | Peritoneal dialysis (n = 14) | p Value | |
|---|---|---|---|
Age (years) | 71 (63–79) | 70 (60–79) | 0.83 |
Male sex | 33 (60) | 7 (50) | 0.45 |
Body mass index (kg/m2) | 21.3 (19.8–24.3) | 23.4 (21.3–24.5) | 0.12 |
Hypertension | 47 (85) | 13 (93) | 0.46 |
Diabetes mellitus | 32 (58) | 5 (36) | 0.13 |
Prior cardiovascular disease | 14 (25) | 3 (21) | 0.76 |
Laboratory data | |||
Haemoglobin (g/dL) | 11.0 (10.5–11.7) | 11.0 (10.5–11.8) | 0.78 |
Haematocrit (%) | 33.9 (32.1–36.5) | 33.8 (33.1–35.9) | 0.70 |
Albumin (g/dL) | 3.5 (3.3–3.8) | 3.5 (3.1–3.7) | 0.35 |
High-sensitive CRP (mg/dL) | 0.06 (0.04–0.29) | 0.09 (0.02–0.43) | 0.82 |
iPTH (pg/mL) | 139 (103–190) | 203 (150–240) | 0.04 |
Transferrin saturation (%) | 22 (16–28) | 37 (24–43) | 0.008 |
Ferritin (ng/mL) | 50 (29–71) | 119 (105–161) | < 0.0001 |
Reticulocyte (%) | 1.7 (1.4–2.1) | 1.3 (1.0–1.7) | 0.06 |
Haptoglobin (mg/dL) | 78 (38–121) | 96 (76–184) | 0.04 |
Lactate dehydrogenase (U/L) | 194 (176–212) | 184 (156–225) | 0.50 |
Iron supplement | 18 (33) | 3 (21) | 0.40 |
Erythropoiesis-stimulating agent (μg/week) | 30 (10–45) | 12 (10–20) | 0.02 |
Erythropoietin resistance index | 9.4 (3.4–14.1) | 3.9 (2.7–7.5) | 0.02 |